HK$2.88
HK$-0.01 (-0.35%)
End-of-day quote: 05/07/2024
SEHK:1177
Add to Portfolio

Sino Biopharmaceutical Annual Report

Year Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
HK$28.78B HK$26.86B HK$23.65B HK$24.23B HK$20.89B HK$14.82B HK$13.54B HK$14.55B HK$12.38B HK$9.90B HK$7.50B HK$5.78B HK$4.09B HK$3.23B HK$2.28B HK$1.16B HK$734.65M HK$756.07M HK$664.30M
GM % Gross Margin %
79.86% 80.15% 78.08% 79.67% 79.91% 79.14% 79.20% 77.67% 76.41% 77.49% 78.52% 78.50% 80.79% 80.23% 79.26% 82.33% 81.11% 81.56% 79.95%
OM Operating Margin
20.43% 15.74% 17.33% 20.00% 19.73% 21.74% 20.00% 19.29% 17.89% 17.29% 18.05% 15.67% 20.84% 22.86% 22.54% 21.16% 15.67% 20.23% 21.45%
EPS Earnings Per Share
HK$0.00 HK$0.16 HK$0.12 HK$0.73 HK$0.17 HK$0.17 HK$0.15 HK$0.12 HK$0.11 HK$0.13 HK$0.07 HK$0.05 HK$0.04 HK$0.03 HK$0.03 HK$0.02 HK$0.02 HK$0.01 HK$0.01 HK$0.11 HK$0.02
Div. Dividends
HK$0.11 HK$0.06 HK$0.07 HK$0.05 HK$0.05 HK$0.03 HK$0.02 HK$0.01 HK$0.01 HK$0.01 HK$0.01 HK$0.02 HK$0.02 HK$0.01 HK$0.01 HK$0.01 HK$0.01 HK$0.00 HK$0.01
PR % Payout Ratio %
91.67% 8.22% 41.18% 29.41% 33.33% 25.00% 18.18% 7.69% 14.29% 20.00% 25.00% 66.67% 66.67% 50.00% 50.00% 100.00% 100.00% 0.00% 50.00%
Sha. Shares
18468.07m 18698.76m 18781.02m 18810.96m 18838.7m 16677.43m 16677.43m 16677.43m 16677.43m 16677.43m 16677.43m 16677.43m 16728.68m 15281.79m 15281.95m 15281.95m 15281.95m 15281.95m 13943.39m
OCF Operating Cash Flow
HK$6.27B HK$5.37B HK$5.33B HK$5.32B HK$5.09B HK$3.73B HK$2.99B HK$2.29B HK$2.30B HK$1.58B HK$1.36B HK$1.09B HK$502.67M HK$686.69M HK$415.55M HK$252.48M HK$119.73M HK$263.73M HK$255.22M
FCF Free Cash Flow
HK$4.51B HK$3.81B HK$3.74B HK$3.18B HK$3.40B HK$2.67B HK$2.25B HK$1.25B HK$1.33B HK$865.20M HK$957.98M HK$657.41M HK$140.96M HK$346.30M HK$224.49M HK$179.03M HK$65.87M HK$193.23M HK$142.00M
FCFS Free Cash Flow Per Share
HK$0.25 HK$0.19 HK$0.19 HK$0.19 HK$0.18 HK$0.16 HK$0.13 HK$0.06 HK$0.11 HK$0.06 HK$0.06 HK$0.05 HK$0.01 HK$0.02 HK$0.01 HK$0.01 HK$0.00 HK$0.01 HK$0.01